Biohaven to continue testing troriluzole in Alzheimer’s patients
Alzheimer’s is a progressive neurodegenerative disorder responsible for 60 to 80% of dementia cases. Credit: Gerd Altmann from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more